1 Product identity
Ingredient risk
No flagged ingredients

Arginine Plus

BrandMetagenicsFiber and Other Nutrients Tablet or Pill 14 ingredients DSLD #295630
Net contents: 120 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2023-08-23
2 Ingredients (14)
IngredientGroupSafety
Total CarbohydratesCarbohydrate
Dietary FiberFiber (unspecified)
FolateFolateConditionally Safe
L-ArginineArginine
GlycineGlycineGenerally Safe
Microcrystalline CelluloseCellulose
CelluloseCellulose
Stearic AcidStearic Acid
SilicaSiliconGenerally Safe
Calcium SilicateCalciumConditionally Safe
Croscarmellose SodiumCroscarmellose
HypromelloseHypromellose
Medium Chain TriglycerideMedium chain triglycerides (MCT)
Hydroxypropyl CelluloseHydroxypropyl cellulose
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
Folate — Conditionally Safe
⚠ May mask B12 deficiency
⚠ Colorectal cancer risk debated
L-Arginine — Limited Evidence
⚠ Hypotension
⚠ May worsen herpes outbreaks
Glycine — Generally Safe
⚠ Well tolerated
Silicon — Generally Safe
⚠ Very low toxicity
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID295630
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2023-08-23
6 More from Metagenics
View Metagenics Safety Scorecard → 118 products
ActiFolateAdvaClearAxis Endo Mango FlavorAzeo-PangenAzeo-PangenAzeo-Pangen Extra Strength
7 Cite this page
Vancouver
Pkhakadze G. Arginine Plus — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 17]. Available from: https://supplement.ge/products/dsld-295630/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG